Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development

Yuqin Sun, Xiao Heng, Guang Hu, Xiumei Bo · 2026

Read Anti-CD19 CAR T-cell therapy for autoimmune diseases: from exploratory clinical trials to quantitative pharmacodynamic modeling development by Yuqin Sun, Xiao Heng, Guang Hu, Xiumei Bo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13620333.txt.

Description

Engineered immune cells that hunt B cells have transformed blood cancer care, and doctors now try them against autoimmune diseases. Yuqin Sun and co-authors review that shift. Autoimmune conditions vary widely, so how a cell dose will behave in a given patient is hard to foresee.

The review surveys early trials of anti-CD19 CAR T cells in these diseases. It then turns to a modeling approach that builds a digital twin of each patient. Such models simulate what a dose will do inside the body and forecast benefit and risk. They can also guide dose choices for each person. The authors sketch an ideal model framework for the field. Their aim is to move these therapies from bold experiments toward planned, personal treatment.

Catalog record

CREATORYuqin Sun, Xiao Heng, Guang Hu, Xiumei Bo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE80 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13620333

Browse the full library · About the Tower of Babel